Next-generation sequencing of pancreatic juice can detect and quantify tumor-promoting mutations, supporting imaging and cytology findings to predict the degree of dysplasia in patients at high risk for pancreatic cancer. Future studies are needed to optimize this approach and determine how it best fits into clinical practice.
from Cancer via ola Kala on Inoreader http://ift.tt/2FlICCq
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου